Halozyme Therapeutics, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 7,468 | 0.0% | 110,960 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 8,557 | 0.0% | 116,670 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 6,310 | 0.0% | 121,300 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 7,740 | 0.0% | 121,300 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 5,657 | 0.0% | 118,318 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 6,881 | 0.0% | 120,206 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 6,489 | 0.0% | 123,940 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 5,366 | 0.0% | 131,909 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 5,134 | 0.0% | 138,898 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 5,543 | 0.0% | 145,100 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 5,900 | 0.0% | 163,581 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 6,713 | 0.0% | 175,790 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 10,268 | 0.0% | 180,451 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 7,119 | 0.0% | 180,054 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 8,000 | 0.0% | 181,827 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 7,191 | 0.0% | 180,309 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 7,880 | 0.0% | 195,973 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 7,843 | 0.0% | 192,803 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 8,822 | 0.0% | 194,267 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 8,362 | 0.0% | 200,581 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 8,600 | 0.0% | 201,360 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 5,402 | 0.0% | 205,542 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 5,480 | 0.0% | 204,396 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 3,677 | 0.0% | 204,396 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 3,877 | 0.0% | 218,645 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 2,226 | 0.0% | 175,248 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 2,410 | 0.0% | 160,748 | 12/31/2013 |